Internal Reference Number: FOI_6841
Date Request Received: 26/10/2022 00:00:00
Date Request Replied To: 11/11/2022 00:00:00
This response was sent via: By Email
Request Summary: Prostate Cancer
Request Category: Private Individuals
| Question Number 1: In the most recent 12 months of data which you have access to, how many patients have been diagnosed with the following stages of prostate cancer: A) Stage 1 and stage 2 - localised prostate cancer B) Stage 3 cancer that has not spread to other parts of the body - locally advanced prostate cancer C) Stage 4 cancer which has spread to other parts of the body - metastatic prostate cancer. | |
| Answer To Question 1: Please see attached document. To accompany this answer to question 1 please also see the documents listed below:  FOI_6841 Q1 & 2.xlsx | |
| Question Number 2: In reference to the answer for question 1: A) what number, for each stage, received novel imaging? B) what was the average, for each stage, time post diagnosis for them to receive the novel imaging? | |
| Answer To Question 2: Please see document attached to question 1. | |
| Question Number 3: In the most recent 12 months of data which you have access to, how many patients in total initially sat within the urology department, but were referred to the oncology department before they develop metastases? | |
| Answer To Question 3: SFT do not hold this information as patients are referred to UHS (Southampton). | |
| Question Number 4: In reference to the answer for question 3, what number of these patients developed metastases prior to being referred to the oncology department. | |
| Answer To Question 4: SFT do not hold this information as patients are referred to UHS (Southampton). | |
| Question Number 5: For all patients who have received darolutamide, what is the average duration of treatment? | |
| Answer To Question 5: 0 Patients have been given darolutamide | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¾¨Ó㴫ý Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
